ATEC · XBRL financial data
Alphatec Holdings financial statements, every quarter
The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal quarters (ATEC's year ends in late December)
| In millions of dollars | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | Mar 31, 2026 | Jun 30, 2026 | Sep 30, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of revenue | 43* | 41 | 43 | 48 | 55* | 53 | 56 | 59 | 63* | 56 | 59 | 63 |
| Gross profit | — | 97 | 103 | 103 | — | 116 | 129 | 137 | — | 136 | 154 | 158 |
| Selling, general and administrative | 104* | 114 | 113 | 109 | 115* | 127 | 119 | 124 | 129* | 137 | 134 | 133 |
| Total operating expenses | 140* | 141 | 138 | 136 | 145* | 160 | 142 | 153 | 158* | 159 | 156 | 155 |
| Operating income (loss) | (45)* | (43) | (35) | (34) | (24)* | (44) | (13) | (16) | (9)* | (23) | (2) | 3 |
| Interest expense | 4* | 5 | 6 | 7 | 7* | 8 | 12 | 13 | 13* | 12 | 11 | 11 |
| Other income (expense) | 0* | 0 | 0 | 1 | (2)* | 0 | 1 | 0 | (0)* | 0 | (1) | (0) |
| Income tax expense (benefit) | (0)* | (0) | (0) | (0) | 0* | (0) | (0) | 0 | (0)* | 0 | 0 | 2 |
| Net income (loss) | (49)* | (48) | (41) | (40) | (33)* | (52) | (41) | (29) | (22)* | (34) | (26) | (5) |
| Earnings per share, basic USD per share | (0.37)* | (0.34) | (0.29) | (0.28) | (0.23)* | (0.35) | (0.27) | (0.19) | (0.14)* | (0.22) | (0.16) | (0.03) |
| Earnings per share, diluted USD per share | (0.37)* | (0.34) | (0.29) | (0.28) | (0.23)* | (0.35) | (0.27) | (0.19) | (0.14)* | (0.22) | (0.16) | (0.03) |
| Weighted average shares, basic millions of shares | 134* | 141 | 143 | 143 | 145* | 147 | 150 | 151 | 152* | 154 | 157 | 157 |
| Weighted average shares, diluted millions of shares | 134* | 141 | 143 | 143 | 145* | 147 | 150 | 151 | 152* | 154 | 157 | 157 |
Balance sheet
CSVFiscal quarters (ATEC's year ends in late December)
Cash flows
CSVFiscal quarters (ATEC's year ends in late December)
| In millions of dollars | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | Mar 31, 2026 | Jun 30, 2026 | Sep 30, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (loss) | (49)* | (48) | (41) | (40) | (33)* | (52) | (41) | (29) | (22)* | (34) | (26) | (5) |
| Stock-based compensation | 21* | 17 | 17* | 17* | 22* | 22 | 16* | 16* | 19* | 24 | 18* | 14* |
| Depreciation and amortization | 16* | 18 | 20* | 21* | 20* | 20 | 19* | 19* | 19* | 19 | 20* | 20* |
| Net cash from operating activities | (25)* | (38) | (11)* | (5)* | 11* | (5) | 16* | 14* | 21* | 1 | 21* | 19* |
| Purchases of property and equipment | 26* | 31 | 34* | 16* | 2* | 10 | 10* | 9* | 13* | 12 | 20* | 13* |
| Net cash from investing activities | (28)* | (34) | (36)* | (20)* | (4)* | (12) | (12)* | (14)* | (16)* | (20) | (23)* | (22)* |
| Proceeds from issuing common stock | 146* | — | — | — | year only | — | — | — | year only | — | — | — |
| Net cash from financing activities | 152* | (4) | 3* | 7* | 51* | 31 | 0* | (1)* | 0* | (2) | (20)* | (36)* |
| Net change in cash | 98* | (77) | (44)* | (19)* | 58* | 14 | 4* | (1)* | 5* | (21) | (21)* | (39)* |
Compare with peers
SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
- A cell reading “not reported” means the filings give no figure for that quarter alone.
| Company | Cash ($M) | Revenue, quarter ($M) | Operating cash flow, quarter ($M) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| Alphatec Holdings | 80 | 221 | 19* | 155.1M | — | 10-QSep 30, 2026 |
| Tandem Diabetes Care | 63 | 255 | (35)* | 69.6M | 13.2 quarters | 10-QJun 30, 2026 |
| Artivion | 77 | 126 | (1.3)* | 48.8M | 61.1 quarters | 10-QJun 30, 2026 |
| CONMED | 48 | 336 | 49* | 29.8M | — | 10-QSep 30, 2026 |
| AtriCure | 168 | 154 | 22* | 50.9M | — | 10-QJun 30, 2026 |
| NovoCure | 97 | 193 | 23 | 116.9M | — | 10-QSep 30, 2026 |
| Lemaitre Vascular | 27 | not reported | 16* | 22.9M | — | 10-QJun 30, 2026 |
| Establishment Labs Holdings | 71 | 68 | (17)* | 29.8M | 4.3 quarters | 10-QJun 30, 2026 |
| Ufp Technologies | 9 | 174 | 16* | 7.7M | — | 10-QJun 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.